Citadel Advisors
NTUS

Citadel Advisors’s Natus Medical Inc NTUS Stock Holding History

Citadel Advisors’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-21,500
Closed -$559K – 15134
2021
Q2 		$559K Sell
21,500
-8,400
-28% -$229K ﹤0.01% 9812
2021
Q1 		$766K Buy
29,900
+5,100
+21% +$131K ﹤0.01% 8744
2020
Q4 		$497K Buy
+24,800
New +$486K ﹤0.01% 8159
2020
Q2 		– Sell
-11,100
Closed -$257K – 10762
2020
Q1 		$257K Buy
+11,100
New +$323K ﹤0.01% 7587
2019
Q2 		– Sell
-23,400
Closed -$594K – 10117
2019
Q1 		$594K Buy
+23,400
New +$698K ﹤0.01% 6500
2018
Q4 		– Sell
-13,900
Closed -$496K – 10005
2018
Q3 		$496K Buy
13,900
+6,200
+81% +$219K ﹤0.01% 6712
2018
Q2 		$266K Sell
7,700
-18,600
-71% -$652K ﹤0.01% 7414
2018
Q1 		$885K Buy
+26,300
New +$832K ﹤0.01% 5007
2017
Q3 		– Sell
-10,200
Closed -$380K – 8237
2017
Q2 		$380K Buy
10,200
+4,800
+89% +$173K ﹤0.01% 5529
2017
Q1 		$212K Sell
5,400
-3,400
-39% -$128K ﹤0.01% 6419
2016
Q4 		$306K Buy
+8,800
New +$345K ﹤0.01% 5641
2016
Q2 		– Sell
-6,000
Closed -$231K – 7594
2016
Q1 		$231K Buy
6,000
+3,500
+140% +$130K ﹤0.01% 5446
2015
Q4 		$120K Sell
2,500
-2,200
-47% -$102K ﹤0.01% 6489
2015
Q3 		$185K Buy
4,700
+500
+12% +$21.2K ﹤0.01% 6254
2015
Q2 		$179K Buy
4,200
+1,100
+35% +$43.8K ﹤0.01% 6465
2015
Q1 		$122K Sell
3,100
-6,100
-66% -$225K ﹤0.01% 6682
2014
Q4 		$332K Buy
9,200
+2,600
+39% +$87.3K ﹤0.01% 5287
2014
Q3 		$195K Sell
6,600
-900
-12% -$24.8K ﹤0.01% 5754
2014
Q2 		$189K Buy
7,500
+7,200
+2,400% +$178K ﹤0.01% 5630
2014
Q1 		$8K Buy
+300
New +$7.56K ﹤0.01% 7582

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's NTUS Position: Q2 2022 in Review

Citadel Advisors sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 11,014 shares — an estimated $289K sold.

Citadel Advisors first reported a position in NTUS in Q2 2013 and held it in 33 quarters. The position peaked at $7.87M in Q2 2017. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Citadel Advisors reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 11,014 Natus Medical Inc shares in Q2 2022, an estimated $289K.
  • Citadel Advisors first reported a position in Natus Medical Inc in Q2 2013 and held it in 33 quarters.
  • Citadel Advisors's Natus Medical Inc position peaked at $7.87M in Q2 2017.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.